Vincent Brichard

Director/Board Member at

eTheRNA immunotherapies NV

Health Technology

Consumer Services

Finance

Profile

Vincent Brichard currently works at ImCyse SA, as Director, eTheRNA immunotherapies NV, as Director, Imcheck Therapeutics SAS, as Director from 2019, FoRx Therapeutics AG, as Director, Nouscom Srl, as Director, Egle Therapeutics SAS, as Director from 2025, and EQT Life Sciences Group BV, as Venture Partner from 2015.
Dr. Brichard also formerly worked at Kiadis Pharma BV, as Member-Supervisory Board, Celyad Oncology SA, as Vice President, and Kiadis Pharma NV, as Independent Member-Supervisory Board.
Dr. Brichard received his doctorate degree from Katholieke Universiteit Leuven, graduate degree from Université Catholique de Louvain, Masters Business Admin degree from Harvard Business School, and doctorate degree from Ludwig Institute For Cancer Research (Belgium).

Vincent Brichard active positions

Companies	Position	Start
eTheRNA immunotherapies NV eTheRNA immunotherapies NV BiotechnologyHealth Technology Operates as a technology platform that develops mRNA and lipid nanoparticle therapeutics	Director/Board Member	-
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Private Equity Investor	01/01/2015
Imcheck Therapeutics SAS Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research	Director/Board Member	04/12/2019
FoRx Therapeutics AG FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops cancer treatment compounds	Director/Board Member	-
Egle Therapeutics SAS Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases	Director/Board Member	-
ImCyse SA ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies	Director/Board Member	-
Nouscom Srl Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer	Director/Board Member	-

All active positions of Vincent Brichard

Former positions of Vincent Brichard

Companies	Position	End
KIADIS PHARMA N.V.	Director/Board Member	-
CELYAD ONCOLOGY SA	Corporate Officer/Principal	-
░░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Vincent Brichard's experience

Training of Vincent Brichard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Vincent Brichard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Finance
Katholieke Universiteit Leuven Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kiadis Pharma BV Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products	Health Technology
Université Catholique de Louvain Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Celyad Oncology SA Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products	Health Technology
ImCyse SA ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies	Health Technology
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kiadis Pharma NV Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products	Health Technology
Ludwig Institute For Cancer Research (Belgium) Ludwig Institute For Cancer Research (Belgium) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
eTheRNA immunotherapies NV eTheRNA immunotherapies NV BiotechnologyHealth Technology Operates as a technology platform that develops mRNA and lipid nanoparticle therapeutics	Health Technology
Imcheck Therapeutics SAS Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research	Health Technology
FoRx Therapeutics AG FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops cancer treatment compounds	Health Technology
Nouscom Srl Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer	Commercial Services
Egle Therapeutics SAS Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases	Health Technology